Market revenue in 2024 | USD 2,800.5 million |
Market revenue in 2030 | USD 4,514.4 million |
Growth rate | 8.4% (CAGR from 2025 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Biologics |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 72.51% in 2024. Horizon Databook has segmented the Germany veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
Germany emphasizes animal welfare and ethics in veterinary medicine. The German market for veterinary medicine is driven by rising animal adoption & cattle population, increasing preventative care for animals, and growing awareness about the significance of the health of farm & companion animals in the country.
Furthermore, according to the International Committee for Animal Recording (ICAR), 50% of German farms specialize in livestock, which is anticipated to drive the veterinary medicine market. Moreover, according to a survey commissioned by Industry ever band Heimtier Bedard (IVH) e.V., 44% of all households in Germany have at least one domestic animal.
Rising partnerships and acquisitions among major players in the country drive the market. For instance, in September 2023, Zoetis acquired a German biotech company, adivo. The acquisition would provide Zoetis access to technological & existing species-specific antibody libraries and the opportunity to develop numerous novel veterinary products.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany veterinary medicine market , including forecasts for subscribers. This country databook contains high-level insights into Germany veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account